John Towns
Advertisement
John Towns is the senior director of global CMC regulatory affairs at Eli Lilly and Company. Towns is also the chair of the Quality by Design Working Group of the PhRMA Biologics and Biotechnology Leadership Committee
Articles by John Towns
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Maximizing Productivity and Scalability with Perfusion Technology
2
Mastering Phase-Appropriate Characterization for Biologics Approval
3
Master Analytical Testing for Biologics Products
4
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
5
